These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33255999)

  • 1. Predictors of Mortality in Patients with Interstitial Lung Disease-Associated Pulmonary Hypertension.
    Alhamad EH; Cal JG; Alrajhi NN; Alharbi WM
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33255999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of mortality in interstitial lung disease patients without pulmonary hypertension.
    Alhamad EH; Cal JG
    Ann Thorac Med; 2020; 15(4):238-243. PubMed ID: 33381239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary vascular resistance estimated by Doppler echocardiography predicts mortality in patients with interstitial lung disease.
    Yasui K; Yuda S; Abe K; Muranaka A; Otsuka M; Ohnishi H; Hashimoto A; Takahashi H; Tsuchihashi K; Takahashi H; Takahashi S; Miura T
    J Cardiol; 2016 Oct; 68(4):300-7. PubMed ID: 27032318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exacerbation in interstitial lung disease.
    Alhamad EH; Cal JG; Alrajhi NN; AlBoukai AA
    Ann Thorac Med; 2021; 16(2):178-187. PubMed ID: 34012485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and hemodynamic characteristics of pulmonary hypertension associated with interstitial lung disease in China.
    Wang L; Zhao QH; Pudasaini B; Jiang R; Gong SG; He J; Yuan P; Liu JM
    Clin Respir J; 2018 Mar; 12(3):915-921. PubMed ID: 28026153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive determinants of pulmonary hypertension in interstitial lung disease.
    Joseph P; Savarimuthu S; Zhao J; Yan X; Oakland HT; Cullinan M; Heerdt PM; Singh I
    Pulm Circ; 2023 Jan; 13(1):e12197. PubMed ID: 36814586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
    Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exertional Desaturation Is More Severe in Idiopathic Pulmonary Fibrosis Than in Other Interstitial Lung Diseases.
    Otake K; Misu S; Fujikawa T; Sakai H; Tomioka H
    Phys Ther Res; 2023; 26(1):32-37. PubMed ID: 37181481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
    Kimura M; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishiyama O; Aso H; Sakamoto K; Hasegawa Y
    Respiration; 2013; 85(6):456-63. PubMed ID: 23257350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
    Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
    Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.
    Mismetti V; Delavenne X; Montani D; Bezzeghoud S; Delezay O; Hodin S; Launay D; Marchand-Adam S; Nunes H; Ollier E; Reynaud-Gaubert M; Pastre J; Traclet J; Quetant S; Zeghmar S; Bertoletti L; Cottin V
    Respir Res; 2023 Nov; 24(1):273. PubMed ID: 37936223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing long-term outcomes in fibrotic interstitial lung disease (F-ILD) diagnosed through multidisciplinary discussion (MDD): a prospective cohort study.
    Liao YW; Liu MC; Wu YC; Hsu CY; Huang WN; Chen YH; Fu PK
    Eur J Med Res; 2024 Jan; 29(1):91. PubMed ID: 38291459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Hemodynamics and Six-Minute Walk Test Outcomes in Patients with Interstitial Lung Disease.
    Nishiyama O; Yamazaki R; Sano H; Iwanaga T; Higashimoto Y; Kume H; Tohda Y
    Can Respir J; 2016; 2016():3837182. PubMed ID: 27445533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD.
    Nathan SD; Chandel A; Wang Y; Xu J; Shao L; Watkins TR; Diviney J; King CS; Han L
    J Heart Lung Transplant; 2024 Apr; 43(4):547-553. PubMed ID: 37979926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.